Document is current
Any future updates will be listed below
-
Authors
Hellstrom, Wayne J. G. https://orcid.org/0000-0003-1284-959X
Dolhain, Radboud J. E. M.
Ritter, Timothy E.
Watkins, Timothy R.
Arterburn, Sarah J.
Dekkers, Goele
Gillen, Angi
Tonussi, Caroline
Gilles, Leen
Oortwijn, Alessandra
Van Beneden, Katrien
de Vries, Dick E.
Sikka, Suresh C.
Vanderschueren, Dirk
Reinisch, Walter
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03926195 at ClinicalTrials.govDocuments that mention this clinical trial
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
https://doi.org/10.1136/ard-2023-223850
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies
https://doi.org/10.1136/ard-2023-224017
MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases
https://doi.org/10.1007/s12325-022-02168-4
-
Funding
Funding for this research was provided by:
Galapagos NV
Gilead Sciences
- License Information
-
More Information
Article History
Received: 21 January 2022
Accepted: 14 April 2022
First Online: 25 May 2022
